(Q38257819)

1 September 2017

1 reference

title

Human immunodeficiency virus and liver transplantation: Hepatitis C is the last hurdle (English)

1 reference

1 September 2017

liver transplantation

1 reference

1 reference

2

Norah A Terrault

1 reference

1 September 2017

Peter G Stock

1

1 reference

PubMed ID

25292153

1 September 2017

language of work or name

English

0 references

publication date

19 March 2015

1 reference

1 September 2017

1 reference

1 September 2017

61

1 reference

1 September 2017

5

1 reference

1 September 2017

1747-1754

1 reference

HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes

1 September 2017

1 reference

Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients.

21 January 2018

1 reference

Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity

21 January 2018

1 reference

Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients

21 January 2018

1 reference

Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection

21 January 2018

1 reference

Liver transplantation in HIV-positive patients.

21 January 2018

1 reference

Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus

21 January 2018

1 reference

Fibrosing cholestatic hepatitis in HIV/HCV co-infected transplant patients-usefulness of early markers after liver transplantation

21 January 2018

1 reference

Peginterferon and ribavirin for treatment of recurrent hepatitis C disease in HCV-HIV coinfected liver transplant recipients

21 January 2018

1 reference

Liver transplantation trends in the HIV population

21 January 2018

1 reference

Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis.

21 January 2018

1 reference

Hepatitis C virus-infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men.

21 January 2018

1 reference

Risk of advanced fibrosis with grafts from hepatitis C antibody-positive donors: a multicenter cohort study

21 January 2018

1 reference

Renal transplantation between HIV-positive donors and recipients

21 January 2018

1 reference

Outcomes of kidney transplantation in HIV-infected recipients

21 January 2018

1 reference

Safety and efficacy of raltegravir in HIV-infected transplant patients cotreated with immunosuppressive drugs.

21 January 2018

1 reference

Safe use of raltegravir and sirolimus in an HIV-infected patient with renal impairment after orthotopic liver transplantation

21 January 2018

1 reference

Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon.

21 January 2018

1 reference

Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers

21 January 2018

1 reference

Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infection.

21 January 2018

1 reference

Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation.

21 January 2018

1 reference

Drug interactions between antiretrovirals and new or emerging direct-acting antivirals in HIV/hepatitis C virus coinfection.

21 January 2018

1 reference

Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: potent antiviral activity but no clinical benefit if treatment is given late

21 January 2018

1 reference

Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis

21 January 2018

1 reference

Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation

21 January 2018

1 reference

Chronic kidney disease after liver transplantation in human immunodeficiency virus/hepatitis C virus-coinfected recipients versus human immunodeficiency virus-infected recipients without hepatitis C virus: results from the National Institutes of Hea

21 January 2018

1 reference

Malignancy in the HIV-infected patients undergoing liver and kidney transplantation

21 January 2018

1 reference

Outcome of HCV/HIV-Coinfected Liver Transplant Recipients: A Prospective and Multicenter Cohort Study

21 January 2018

1 reference

Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HEP.27553

1 reference

1 September 2017

1 reference

PubMed ID

25292153